No delay in the start of therapy for head and neck tumor patients in the COVID-19 pandemic – evaluation using the example of oropharyngeal carcinoma

Introduction Fear of physician visits, fewer screenings, resource reduction and resource shifting in the clinic due to the care of corona patients may have led to a delay between initial contact with a patient and therapy initiation since 2020. This study shows that there has been no delay in therapy initiation due to resource optimization, content restructuring and organization. This is illustrated by the example of patients with initial diagnosis of oropharyngeal carcinoma.